Table 1 |.
Cell type | Pathway and/ or signalling molecules | Effect |
---|---|---|
Innate immune system | ||
Type 3 innate lymphoid cell | IL-23R/STAT5 | Cell activation Cytokine production (IL-17A, IL-22) Antimicrobial effects |
Granulocyte | IL-23R | Cell activation Pro-inflammatory cytokine production |
Natural killer/intraepithelial lymphocytes | IL-23R | Cytotoxicity Cell activation Pro-inflammatory cytokine production |
Adaptive immune system | ||
Treg Cells, Teff cells, TH17 cells |
IL-23R RORγt (Teff cells) |
Suppression of Treg cells Proliferation and expansion of TH17 cells Production of IL-6 and TH17 cytokines |
Intestinal epithelial cells | IL-22 Regenerating gene family proteins | Increased barrier function Antimicrobial effects |
Interleukin-23 (IL-23) exerts effects on both innate and adaptive immune cells. In type 3 innate lymphoid cells, granulocytes, intraepithelial lymphocytes and natural killer cells, IL-23 induces cell activation and cytokine production. Additional effects of IL-23 are related to adaptive immune cells, such as regulatory T (Treg) cells, and effector T (Teff) cells, such as T helper 17 (TH17) cells. In this context, IL-23 suppresses Treg cells, whereas it activates TH17 cells. Furthermore, this cytokine regulates barrier function and production of antimicrobial peptides in intestinal epithelial cells. IL-23R, IL-23 receptor; RORγt, retinoid-related orphan receptor-γt; STAT, signal transducer and activator of transcription.